Optimum Investment Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-126
Closed -$6K 833
2022
Q2
$6K Hold
126
﹤0.01% 649
2022
Q1
$7K Hold
126
﹤0.01% 684
2021
Q4
$7K Buy
+126
New +$6.5K ﹤0.01% 706
2021
Q3
Sell
-2,351
Closed -$146K 853
2021
Q2
$146K Hold
2,351
0.05% 322
2021
Q1
$153K Hold
2,351
0.04% 309
2020
Q4
$155K Hold
2,351
0.05% 288
2020
Q3
$122K Hold
2,351
0.04% 302
2020
Q2
$116K Hold
2,351
0.04% 300
2020
Q1
$120K Hold
2,351
0.05% 280
2019
Q4
$130K Hold
2,351
0.04% 349
2019
Q3
$118K Buy
+2,351
New +$118K 0.04% 346
2014
Q4
Sell
-89
Closed -$3K 990
2014
Q3
$3K Hold
89
﹤0.01% 867
2014
Q2
$3K Hold
89
﹤0.01% 873
2014
Q1
$3K Hold
89
﹤0.01% 696
2013
Q4
$2K Hold
89
﹤0.01% 722
2013
Q3
$2K Buy
+89
New +$2.29K ﹤0.01% 684

Other funds holding EHC

Optimum Investment Advisors's EHC Position: Q3 2022 in Review

Optimum Investment Advisors sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 126 shares — an estimated $6K sold.

Optimum Investment Advisors first reported a position in EHC in Q3 2013 and held it in 16 quarters. The position peaked at $155K in Q4 2020. 346 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

  • Optimum Investment Advisors reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
  • Optimum Investment Advisors sold 126 Encompass Health shares in Q3 2022, an estimated $6K.
  • Optimum Investment Advisors first reported a position in Encompass Health in Q3 2013 and held it in 16 quarters.
  • Optimum Investment Advisors's Encompass Health position peaked at $155K in Q4 2020.
  • 346 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on Optimum Investment Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.